38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	Is a	General adjectival modifier	false	Inferred relationship	Some
un	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Warfarin sodium 5 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Warfarin sodium 5 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Somatrem 10 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Somatrem 10 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Sodium cromoglicate 20 mg/actuation powder for inhalation	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Sodium cromoglicate 20 mg/actuation powder for inhalation	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Dinoprostone 10 mg prolonged-release vaginal pessary	Count of base of active ingredient	False	un	Inferred relationship	Some
Dinoprostone 10 mg prolonged-release vaginal pessary	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Sulfasalazine 30 mg/mL rectal suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Sulfasalazine 30 mg/mL rectal suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 775 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 775 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Hexachlorophene 30 mg/mL cutaneous emulsion	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Hexachlorophene 30 mg/mL cutaneous emulsion	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Selenium sulfide 25 mg/mL cutaneous lotion	Count of base of active ingredient	False	un	Inferred relationship	Some
Selenium sulfide 25 mg/mL cutaneous lotion	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial	Has presentation strength numerator value	False	un	Inferred relationship	Some	1
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	un	Inferred relationship	Some	1

Start Previous Page 201 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module